Humana (HUM) Aktie Kurs
Humana Kurs
De seneste 19 år voksede Humanas omsætning med 9,9 % årligt og nåede 129,66 Mrd. USD. Indtjening pr. aktie er vokset med 6,7 % om året de seneste 19 år. For Humana er nettoavance på 0,9 % ned i forhold til 3,5 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 0,85 %. Udlodningsandelen er omkring 36 % af indtjeningen. Udbyttet er vokset med 11,7 % om året de seneste 14 år. Konsensus 12-måneders kursmål for Humana er 412,50 USD, cirka under kursen med 1,3 %. Af 33 analytikere anbefaler 16 køb — den samlede vurdering er Hold.
Humana aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Humana aktie og aktieanalyse
Hyppigt stillede spørgsmål om Humana-aktien
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 416,78 USD for Humana-aktien (median: 412,50 USD), svarende til -2,5 % i forhold til seneste kurs. Konsensus bygger på 33 analytikervurderinger.
33 analytikere vurderer i øjeblikket Humana-aktien: 16 anbefaler køb, 16 hold og 1 salg. For 2026 forventer analytikere, at Humana genererer omsætning på 162,52 Mrd. USD og indtjening pr. aktie på 9,14 USD.
Omregnet til den aktuelle valutakurs handles Humana-aktien til 371,72 EUR (417,89 USD).
Humana-aktien (HUM) er noteret på 7 børser, herunder: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
forventet-omsætningen for Humana er 162,52 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
forventet-overskuddet for Humana er 1,10 Mrd. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Humana er i øjeblikket 45,74. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Humana-aktien.
Pris-til-salgs-forholdet (P/S) for Humana er i øjeblikket 0,31. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Humana-aktien.
AlleAktien-kvalitetsscore for Humana er 5/10.
ISIN for Humana er US4448591028. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Humana er 856584. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Humana er HUM. Tickersymbolet bruges til at handle Humana-aktier på børsen.
Humana aktie
Humana Ticker
Humana FIGI
Alle fundamentale data om Humana i deep dive
Vores aktieanalyse af Humana-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Humana. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: